Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Amgen
- 18 Dec 2017 Status changed from active, no longer recruiting to completed.
- 05 Jul 2017 Planned End Date changed from 27 Nov 2017 to 19 Nov 2017.
- 05 Jul 2017 Planned primary completion date changed from 23 Aug 2017 to 15 Aug 2017.